Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026390

Chief Business Officer acquired 38,596 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Finnegan Frederick Chief Business Officer 2021-10-22 Grant or award +38,596 38,596 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Finnegan Frederick Chief Business Officer 2021-10-22 Grant or award · Earnout Rights (Common Stock) +15,593 15,593 D: show line 2 in the form
Finnegan Frederick Chief Business Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +23,264 23,264 D: show line 3 in the form
Finnegan Frederick Chief Business Officer 2021-10-22 Grant or award · Employee Stock Option (right to buy) +125,627 125,627 D: show line 4 in the form
Finnegan Frederick Chief Business Officer 2021-10-22 Grant or award · Earnout Rights (Restricted Stock Units) +60,152 60,152 D: show line 5 in the form
Loading xslF345X03/ownership.xml…